Oleander Medical Technologies is developing a revolutionary new treatment to destroy many of the most invasive and deadly cancers using a process called Targeted Osmotic Lysis (TOL).Unlike radiation or chemotherapy, TOL has the potential to destroy cancer without ravaging the rest of the body, to eliminate the disease in a matter of minutes, without pain and with minimal discomfort, and at a much lower cost than current treatments.
View Top Employees from Oleander Medical TechnologiesWebsite | http://www.oleandermedicaltechnologies.com |
Revenue | $4 million |
Employees | 5 (4 on RocketReach) |
Founded | 2012 |
Address | 340 East Parker Center, Baton Rouge, Louisiana 70803, US |
Phone | (225) 413-7658 |
Technologies |
JavaScript,
HTML,
Twitter
+10 more
(view full list)
|
Industry | Biotechnology Research, Manufacturing General, Biotechnology, Manufacturing, Science and Engineering, Clinical Trials, Health Care, Communities, Community and Lifestyle, Medical Device |
SIC | SIC Code 384 Companies, SIC Code 38 Companies |
NAICS | NAICS Code 33 Companies, NAICS Code 339 Companies |
Looking for a particular Oleander Medical Technologies employee's phone or email?
The Oleander Medical Technologies annual revenue was $4 million in 2024.
Paige Miller is the President of Oleander Medical Technologies.
4 people are employed at Oleander Medical Technologies.
Oleander Medical Technologies is based in Baton Rouge, Louisiana.
The NAICS codes for Oleander Medical Technologies are [33, 339].
The SIC codes for Oleander Medical Technologies are [384, 38].